Home/CereMark Pharma/Robert P. Fitzsimmons, JD
RP

Robert P. Fitzsimmons, JD

Managing Director, Founder

CereMark Pharma

CereMark Pharma Pipeline

DrugIndicationPhase
F-18 Flornaptitril (F-18 FNT)Detection of tau and amyloid pathology for predicting progression in Mild Cognitive Impairment due to Alzheimer's Disease or Chronic Traumatic EncephalopathyPre-clinical / IND-enabling